|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 62.55 USD | +2.88% |
|
+2.09% | -23.61% |
| Market Cap | 2.69B 2.32B 2.13B 2.01B 3.78B 254B 3.81B 25.3B 9.85B 125B 10.1B 9.88B 431B | P/E 2026 * |
-97.7x | P/E 2027 * | 20x |
|---|---|---|---|---|---|
| Enterprise Value | 2.69B 2.32B 2.13B 2.01B 3.78B 254B 3.81B 25.3B 9.85B 125B 10.1B 9.88B 431B | EV / Sales 2026 * |
3.86x | EV / Sales 2027 * | 2.98x |
| Free-Float |
96.93% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Tarsus Pharmaceuticals, Inc.
| 1 day | +2.88% | ||
| 1 week | +2.09% | ||
| Current month | +5.30% | ||
| 1 month | +0.11% | ||
| 3 months | -10.37% | ||
| 6 months | -19.57% | ||
| Current year | -23.61% |
| 1 week | 60.08 |  | 63.61 |
| 1 month | 56 | | 65.27 |
| Current year | 56 | | 83.92 |
| 1 year | 38.51 | | 85.25 |
| 3 years | 12.57 | | 85.25 |
| 5 years | 10.8 | | 85.25 |
| 10 years | 10.8 | | 85.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bobak Azamian
CEO | Chief Executive Officer | 48 | 01/09/2018 |
Jeffrey Farrow
DFI | Director of Finance/CFO | 64 | 24/04/2023 |
| Chief Tech/Sci/R&D Officer | 47 | 04/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Bobak Azamian
CHM | Chairman | 48 | 02/12/2022 |
| Director/Board Member | 71 | 01/12/2019 | |
Bill Link
BRD | Director/Board Member | 80 | 01/01/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-24 | Fiscal year | Director | 2,766 | 0.0065% | ||
| 03-20 | Sell | Chief Operating Officer | 2,989 | 0.0070% | ||
| 03-17 | Sell | General Counsel | 12,440 | 0.0292% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.88% | +2.09% | +58.68% | +237.93% | 2.62B | |
| -1.11% | +1.04% | +19.47% | -22.36% | 62.54B | |
| +0.96% | -4.54% | +59.60% | +194.24% | 55.22B | |
| +2.78% | +37.00% | +37.00% | +37.00% | 40.9B | |
| +0.04% | -0.44% | -55.88% | -62.47% | 35.99B | |
| +1.56% | +2.28% | +56.98% | -33.22% | 28.88B | |
| +11.55% | +34.38% | +141.88% | -51.99% | 21.98B | |
| -0.76% | -6.07% | +43.86% | +56.56% | 19.93B | |
| -2.03% | +0.67% | -2.92% | +103.95% | 16.95B | |
| +2.32% | +1.24% | +56.95% | +95.04% | 15.87B | |
| Average | +0.77% | +4.51% | +41.56% | +55.47% | 30.09B | |
| Weighted average by Cap. | +0.53% | +3.77% | +35.42% | +38.26% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 696M 601M 552M 520M 977M 65.72B 985M 6.55B 2.55B 32.25B 2.61B 2.56B 112B | 905M 780M 717M 675M 1.27B 85.36B 1.28B 8.5B 3.31B 41.89B 3.39B 3.32B 145B |
| Net income | -28.48M -24.57M -22.59M -21.26M -39.95M -2.69B -40.28M -268M -104M -1.32B -107M -105M -4.56B | 158M 136M 125M 118M 222M 14.91B 223M 1.48B 578M 7.32B 593M 580M 25.31B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/06/26 | 62.55 $ | +2.88% | 462,277 |
| 16/06/26 | 60.80 $ | -1.70% | 718,792 |
| 15/06/26 | 61.85 $ | -0.16% | 502,415 |
| 12/06/26 | 61.95 $ | -1.05% | 267,322 |
| 11/06/26 | 62.61 $ | +2.19% | 399,703 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TARS Stock
Select your edition
All financial news and data tailored to specific country editions
